The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review
Planta Medica · 01.03.2024 · 90 (03) · 172-203
DOI: 10.1055/a-2209-6357 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Planta Medica, erschienen am 01.03.2024. Verfasst von Zahra Alipour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant Sciences and Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran. Hauptthemen laut MEDLINE: COVID-19, Hepatitis C, Chronic, Severe acute respiratory syndrome-related coronavirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 315 Literaturangaben.
Abstract (Originalsprache)
In early 2020, a global pandemic was announced due to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), known to cause COVID-19. Despite worldwide efforts, there are only limited options regarding antiviral drug treatments for COVID-19. Although vaccines are now available, issues such as declining efficacy against different SARS-CoV-2 variants and the aging of vaccine-induced immunity highlight the importance of finding more antiviral drugs as a second line of defense against the disease. Drug repurposing has been used to rapidly find COVID-19 therapeutic options. Due to the lack of clinical evidence for the therapeutic benefits and certain serious side effects of repurposed antivirals, the search for an antiviral drug against SARS-CoV-2 with fewer side effects continues. In recent years, numerous studies have included antiviral chemicals from a variety of plant species. A better knowledge of the possible antiviral natural products and their mechanism against SARS-CoV-2 will help to develop stronger and more targeted direct-acting antiviral agents. The aim of the present study was to compile the current data on potential plant metabolites that can be investigated in COVID-19 drug discovery and development. This review represents a collection of plant secondary metabolites and their mode of action against SARS-CoV and SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plant Sciences and Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
ORCID-Profile: Ali Akbar Ghotbi-Ravandi
Zitieren
APA
Alipour, Z., Zarezadeh, S., & Ghotbi-Ravandi, A. A. (2024). The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review. Planta Medica, 90(03), 172-203. https://doi.org/10.1055/a-2209-6357
Vancouver
Alipour Z, Zarezadeh S, Ghotbi-Ravandi AA. The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review. Planta Medica. 2024;90(03):172-203. doi:10.1055/a-2209-6357
BibTeX
@article{Alipour2024,
author = {Alipour, Zahra and Zarezadeh, Somayeh and Ghotbi-Ravandi, Ali Akbar},
title = {The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review},
journal = {Planta Medica},
year = {2024},
volume = {90},
number = {03},
pages = {172--203},
doi = {10.1055/a-2209-6357}
}
EUVIMED